Drs. Stephanie and Sudhir on Founding Covalent Bioscience Focusing on E-vaccines, Healthy Ageing, and Catabodies – 79
- March 5, 2019
- Tagged as: age associated, antibodies, biotech, biotechnology, catabodies, Catalytic Immunotherap, co founder, covalent bioscience, deep tech, diseases, E-vaccine, ead E-Vaccine holds promise for effective prophylaxis and therapy of HIV infection, Healthy ageing, learning podcast, learning with lowell, long form interview podcast, Lowell Thompson, medical needs, Principle Scientist, science long form podcast, science podcast, Space, Stephanie Planque, Stephanie Planque Principle Scientist, Sudhir Paul, Sudhir Paul co founder, vaccines
Podcast: Play in new window | Download (Duration: 1:15:57 — 57.5MB) | Embed
Subscribe: Apple Podcasts | Spotify | Amazon Music | Android | Pandora | iHeartRadio | Blubrry | Podcast Index | TuneIn | RSS | More
E-vaccine, catabodies, healthy ageing,and age-associated diseases discussed with Stephanie and Sudhir founders of Covalent Bioscience.